Lindgren N, Xu Z Q, Herrera-Marschitz M, Haycock J, Hökfelt T, Fisone G
Department of Neuroscience, Karolinska Institutet, Berzelius Väg 3, S-171 77, Stockholm, Sweden.
Eur J Neurosci. 2001 Feb;13(4):773-80. doi: 10.1046/j.0953-816x.2000.01443.x.
In the striatum, dopamine release is inhibited by activation of dopamine D(2) autoreceptors. Changes in dopamine release have been attributed to changes in the synthesis of dopamine, which is regulated via phosphorylation of tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of catecholamines. Here, we have studied the involvement of dopamine D(2) receptors in the regulation of TH phosphorylation at distinct seryl residues, using phosphorylation site-specific antibodies and a preparation of rat striatal slices. The D(2) receptor agonist, quinpirole, reduced basal TH phosphorylation at Ser40 but not at Ser19 or Ser31. Quinpirole was also able to reduce the increase in Ser40 phosphorylation caused by forskolin, an activator of adenylyl cyclase, without affecting the increase in Ser19 phosphorylation produced by the glutamate receptor agonist, N-methyl-D-aspartate (NMDA). In addition, the dopamine D(2) receptor agonist reduced both basal and forskolin-stimulated activity of TH, measured as 3,4-dihydroxyphenylalanine (DOPA) accumulation. Quinpirole decreased phosphorylation of Ser40 induced by okadaic acid, an inhibitor of protein phosphatase 1 and 2A and Ro-20-1724, a phosphodiesterase inhibitor. In contrast, quinpirole did not affect the increase in Ser40 phosphorylation caused by the cAMP analogue, 8-Br-cAMP. These data indicate that, in the striatum, activation of dopamine D(2) receptors results in selective inhibition of TH phosphorylation at Ser40 via reduction of the activity of adenylyl cyclase. They also provide a molecular mechanism accounting for the ability of dopamine D(2) autoreceptors to inhibit dopamine synthesis and release from nigrostriatal nerve terminals.
在纹状体中,多巴胺D(2)自身受体的激活会抑制多巴胺释放。多巴胺释放的变化归因于多巴胺合成的改变,而多巴胺合成是通过酪氨酸羟化酶(TH)的磷酸化来调节的,TH是儿茶酚胺合成中的限速酶。在此,我们使用磷酸化位点特异性抗体和大鼠纹状体切片制备物,研究了多巴胺D(2)受体在不同丝氨酸残基处对TH磷酸化调节中的作用。D(2)受体激动剂喹吡罗降低了Ser40处的基础TH磷酸化,但对Ser19或Ser31处的磷酸化没有影响。喹吡罗还能够降低由腺苷酸环化酶激活剂福斯可林引起的Ser40磷酸化增加,而不影响谷氨酸受体激动剂N-甲基-D-天冬氨酸(NMDA)产生的Ser19磷酸化增加。此外,多巴胺D(2)受体激动剂降低了以3,4-二羟基苯丙氨酸(DOPA)积累衡量的基础和福斯可林刺激的TH活性。喹吡罗降低了由蛋白磷酸酶1和2A抑制剂冈田酸以及磷酸二酯酶抑制剂Ro-20-1724诱导的Ser40磷酸化。相反,喹吡罗不影响由cAMP类似物8-溴-cAMP引起的Ser40磷酸化增加。这些数据表明,在纹状体中,多巴胺D(2)受体的激活通过降低腺苷酸环化酶的活性导致对Ser40处TH磷酸化的选择性抑制。它们还提供了一种分子机制,解释了多巴胺D(2)自身受体抑制多巴胺合成和从黑质纹状体神经末梢释放的能力。